Long-term effects of insulin glargine on the risk of breast cancer

Long-Term Metformin Use Is Associated With Decreased Risk of Breast Cancer

(2010) M. Bodmer et al.   DIABETES CARE

Doses of Insulin and Its Analogues and Cancer Occurrence in Insulin-Treated Type 2 Diabetic Patients

(2010) E. Mannucci et al.   DIABETES CARE

Long-acting insulin analogues elicit atypical signalling events mediated by the insulin receptor and insulin-like growth factor-I receptor

(2010) E. Yehezkel et al.   DIABETOLOGIA

Insufficient evaluation of adverse events is not a proof of safety

(2010) L. G. Hemkens et al.   DIABETOLOGIA

Diabetes therapy and cancer risk: causal effects and other plausible explanations

(2010) S. Hernández-Díaz et al.   DIABETOLOGIA

In Vitro Metabolic and Mitogenic Signaling of Insulin Glargine and Its Metabolites

(2010) Mark R. Sommerfeld et al.   PLoS One

Treatment with insulin glargine (Lantus®) increases the proliferative potency of the serum of patients with type-1 diabetes: a pilot study on MCF-7 breast cancer cells

(2010) Doris Mayer et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY

Efficacy and safety of insulin analogues for the management of diabetes mellitus: a meta-analysis

(2009) S. R. Singh et al.   CANADIAN MEDICAL ASSOCIATION JOURNAL

Combined randomised controlled trial experience of malignancies in studies using insulin glargine

(2009) P. D. Home et al.   DIABETOLOGIA

Insulin glargine use and short-term incidence of malignancies—a population-based follow-up study in Sweden

(2009) J. M. Jonasson et al.   DIABETOLOGIA

No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis

(2009) A. Dejgaard et al.   DIABETOLOGIA

Use of insulin glargine and cancer incidence in Scotland: a study from the Scottish Diabetes Research Network Epidemiology Group

(2009) H. M. Colhoun et al.   DIABETOLOGIA

The influence of glucose-lowering therapies on cancer risk in type 2 diabetes

(2009) C. J. Currie et al.   DIABETOLOGIA

Risk of malignancies in patients with diabetes treated with human insulin or insulin analogues: a cohort study

(2009) L. G. Hemkens et al.   DIABETOLOGIA

Analysis of signaling pathways related to cell proliferation stimulated by insulin analogs in human mammary epithelial cell lines

(2009) Ashish Shukla et al.   ENDOCRINE-RELATED CANCER

Insulin glargine and malignancy: an unwarranted alarm

(2009) Stuart J Pocock et al.   LANCET

Phosphorylated Insulin-Like Growth Factor-I/Insulin Receptor Is Present in All Breast Cancer Subtypes and Is Related to Poor Survival

(2008) J. H. Law et al.   CANCER RESEARCH

Insulin receptor expression by human prostate cancers

(2008) Michael E. Cox et al.   PROSTATE

Similarities and differences between insulin and IGF-I: Structures, receptors, and signalling pathways

(2008) Haim Werner et al.   ARCHIVES OF PHYSIOLOGY AND BIOCHEMISTRY